Deal With mNEMOSCIENCE GmbH Uniquely Positions Aporo to Deliver Innovative Biodegradable Medical Devices
SAN FRANCISCO--(BUSINESS WIRE)--Aporo Biomedical, a San Francisco/Bay Area-based medical device company, today reported an exclusive global licensing agreement with mNEMOSCIENCE GmbH for its proprietary biodegradable shape memory polymers (BIO-SMP™). Aporo’s goal is to provide significant clinical value by delivering novel transcatheter devices that close defects and then biodegrade over time, leaving behind no permanent implant. Initially, Aporo will use these materials to treat Patent Foramen Ovale (PFO), a type of structural heart disease that involves closing an open tunnel between the upper left and right chambers of the heart. In the future, the company will use the polymers in devices to treat Atrial Septal Defect (ASD), another structural heart disease, and for vascular closure after catheter-based interventional procedures.
press release >> http://www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20080130005434&newsLang=en
No comments:
Post a Comment